INS and Hyperglycemia: Although glucose control effect of insulin therapy in patients with T2DM has been widely acknowledged, uncontrolled hyperglycaemia was reported by patients as one of the reasons for interrupting/discontinuing insulin therapy after initiation.24 In this study, 9% of discontinuers self‐reported unsatisfied glycaemic control as the reason for their discontinuation.